Bing, Nan,Briley, Linda Perry,Budde, Laura R.,Cox, Charles J.,Spraggs, Colin F.
申请号：
AU2010284092
公开号：
AU2010284092A1
申请日:
2010.08.20
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
Methods are provided of treating a human for cancer comprising administering at least one dose of lapatinib, or a pharmaceutically acceptable salt or composition thereof, to a patient, wherein said patient does not have one or more allelic polymorphisms selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701. Patients may also be free of genotypes in TNXB； rs12153855 and/or rs17207923.
